Pioneering Method Streamlines Colistin Testing for Multi-Drug Resistant Infections

Doctors at BJ Medical College in Pune have developed a faster and more accurate method to test the susceptibility of colistin, a critical antibiotic for treating multi-drug resistant infections. The new method, colistin broth disk elution (CBDE), offers significant advantages over the traditional broth microdilution (BMD) method.

ColistinAntibioticMdr InfectionsCbdeBmdReal Estate PuneOct 04, 2025

Pioneering Method Streamlines Colistin Testing for Multi-Drug Resistant Infections
Real Estate Pune:Pune: Doctors at the microbiology department of BJ Medical College have made a groundbreaking discovery in the field of antimicrobial testing. They have developed a new method to examine the susceptibility of colistin, a ‘last resort’ antibiotic used for patients battling multi-drug resistant (MDR) infections. This new method, known as colistin broth disk elution (CBDE), not only saves time but is also more accurate, ensuring the potent drug is given only to patients who will benefit from it.

The importance of colistin in treating MDR infections cannot be overstated. However, before administering colistin, which is highly nephrotoxic (damaging to the kidneys), it is crucial for doctors to confirm its effectiveness against the specific MDR infection to prevent adverse outcomes. Until now, broth microdilution (BMD) has been the gold standard for testing colistin susceptibility. However, BMD is a labor-intensive method and not practical for routine use in many laboratories.

Rajesh Karyakarte, the head of the microbiology department at BJ Medical College (BJMC) and the corresponding author for the study, explained the significance of the new method. “The new method, colistin broth disk elution (CBDE), showed high categorical agreement with BMD and low error rates, making it a viable alternative. Given its simplicity, cost-effectiveness, and reproducibility, CBDE can support antimicrobial stewardship efforts in resource-limited settings,” he said.

The study has led to an innovative method of testing the susceptibility of colistin in high-risk patients admitted to the ICU for serious infectious diseases. Despite its high neurotoxicity, colistin often becomes the only option in many cases for intensivists attending to patients. The CBDE method will help understand the susceptibility of the drug without the need for dilution, saving up to an hour per patient—a crucial factor in government hospitals—while also conserving manpower. The test results are more accurate than the BMD method, aiding better decision-making in patient treatment.

Karyakarte further elaborated, “The research paper titled ‘Comparison of Broth Disk Elution and Broth Microdilution Methods for Colistin Susceptibility Testing in Carbapenem-Resistant Enterobacteriaceae and Pseudomonas aeruginosa’ was published in Cureus, a peer-reviewed journal, on September 8. The paper has been sent to the Ministry of Health and Family Welfare for further consideration. The new method needs more validation, and only then can a policy decision be made to replace BMD with the CBDE method to test colistin susceptibility.”

This development is particularly significant in the context of healthcare in resource-limited settings, where rapid and accurate testing methods are essential to combat the growing threat of multi-drug resistant infections. The CBDE method has the potential to revolutionize the way colistin susceptibility is tested, ultimately leading to better patient outcomes and more efficient use of medical resources.

Frequently Asked Questions

What is colistin and why is it important?

Colistin is a ‘last resort’ antibiotic used to treat multi-drug resistant (MDR) infections. It is particularly important because it often becomes the only option when other antibiotics fail.

What is the traditional method for testing colistin susceptibility?

The traditional method for testing colistin susceptibility is broth microdilution (BMD), which is considered the gold standard but is labor-intensive and not practical for routine use in many laboratories.

What is the new method developed by doctors at BJ Medical College?

The new method is called colistin broth disk elution (CBDE). It is faster, more accurate, and more cost-effective than BMD, making it a viable alternative for testing colistin susceptibility.

How does the CBDE method work?

The CBDE method involves using a disk containing colistin and placing it in a broth medium with the bacteria. The results are more accurate and can be obtained faster, without the need for dilution.

What are the potential benefits of using the CBDE method?

The CBDE method saves time, conserves manpower, and provides more accurate results compared to BMD. It is particularly useful in resource-limited settings and can help in better decision-making for patient treatment.

Related News Articles

RERA Cases Weekly Round-Up: Relief for Homebuyers Across India
Real Estate Maharashtra

RERA Cases Weekly Round-Up: Relief for Homebuyers Across India

From refund orders to structural defect rectification

May 27, 2024
Read Article
Gurugram Leads Housing Price Surge, Mumbai Lagging Behind
Real Estate Pune

Gurugram Leads Housing Price Surge, Mumbai Lagging Behind

In the last five years, the average price of new housing projects in India’s top 10 cities has surged by 88%, with Gurugram leading the pack at a 160% increase. Mumbai, on the other hand, has seen the lowest rise at 37%. This surge is attributed to massiv

October 16, 2024
Read Article
Anant Raj Reports 75% Increase in Net Profit for Q2 FY25
Real Estate Mumbai

Anant Raj Reports 75% Increase in Net Profit for Q2 FY25

Anant Raj has announced a significant 75% increase in its net profit for the second quarter of the fiscal year 2025. The company also reported a 53.67% rise in its net consolidated total income. This robust growth is a testament to the company's strategic

October 28, 2024
Read Article
DLF JV Firm Sells IT Park in West Bengal's Largest Real Estate Deal for Rs 637 Cr
real estate news

DLF JV Firm Sells IT Park in West Bengal's Largest Real Estate Deal for Rs 637 Cr

In a significant move, DLF, the country's largest real estate developer by market cap, has completed the sale of an IT park in West Bengal for Rs 637 crore. The deal, involving a joint venture firm, marks one of the largest real estate transactions in the

November 29, 2024
Read Article
Eleganz Interiors Files DRHP with NSE Emerge
real estate news

Eleganz Interiors Files DRHP with NSE Emerge

Eleganz Interiors plans to use Rs 25 crore from the IPO proceeds to repay a portion of its outstanding borrowings, as it files its DRHP with NSE Emerge.

December 12, 2024
Read Article
Tata Steel Slapped with Rs 146 Mn Fine for Delay in Stamp Duty Payment
Real Estate Maharashtra

Tata Steel Slapped with Rs 146 Mn Fine for Delay in Stamp Duty Payment

Tata Steel, one of India's leading steel producers, has been penalized with a fine of Rs 146 million by the Maharashtra government for failing to timely pay the stamp duty. The fine, as per the company's exchange filing, highlights the importance of adher

January 14, 2025
Read Article